Showing results (1241-1250 of 1,268) with videos related to
Sort By:
Pageof 127
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 4, 2020
High-Resolution Manometry Thresholds and Motor Patterns Among Asymptomatic IndividualsArvind Rengarajan, Benjamin D Rogers, Zhiqin Wong, et al.Journal of Pediatric Gastroenterology and Nutrition|July 16, 2024
Ineffective esophageal motility: Characterization and outcomes across pediatric neurogastroenterology and motility centers in the United StatesTrevor A Davis, Benjamin D Rogers, Alejandro Llanos-Chea, et al.Neurogastroenterology and Motility|October 23, 2020
Esophagogastric junction morphology and contractile integral on high-resolution manometry in asymptomatic healthy volunteers: An international multicenter studyBenjamin D Rogers, Arvind Rengarajan, Luiz Abrahao, et al.Bioscience|January 8, 2026
The Future of Artificial Intelligence in Ecosystem ModelingScott Spillias, Rowan Trebilco, Matthew P Adams, et al.Annals of Surgery|May 5, 2025
Abnormal Milan Score and Compromised Esophageal Mucosal Integrity Stratify Gastroesophageal Reflux Disease SeverityMarco Sozzi, Stefano Siboni, Pierfrancesco Visaggi, et al.United European Gastroenterology Journal|March 27, 2024
The Milan score: A novel manometric tool for a more efficient diagnosis of gastro-esophageal reflux diseaseStefano Siboni, Marco Sozzi, Ivan Kristo, et al.Alimentary Pharmacology & Therapeutics|June 20, 2025
Combined Lyon and Milan Scores Predict Gerd Management Outcome Better Than Either Score Alone or Their Individual ComponentsStefano Siboni, Marco Sozzi, Pierfrancesco Visaggi, et al.Neurogastroenterology and Motility|January 6, 2025
The Milan Score Predicts Objective Gastroesophageal Reflux Disease in Patients With Type 2 Esophagogastric JunctionDavide Ferrari, Stefano Siboni, Marco Sozzi, et al.Journal of Medicinal Chemistry|December 15, 2015
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of OsteoarthritisPeter G Ruminski, Mark Massa, Joseph Strohbach, et al.Science (New York, N.Y.)|August 7, 2004
Initial results from the Mini-TES experiment in Gusev Crater from the Spirit RoverP R Christensen, S W Ruff, R L Fergason, et al.Pageof 127